Toth Financial Advisory Corp Innoviva, Inc. Transaction History

Toth Financial Advisory Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 15, 2019	SELL	$10.05 - $14.55 $20,100 - $29,100	-2,000 Closed	0 $0
Q2 2019 Jul 17, 2019	SELL	$13.1 - $14.95 $39,300 - $44,850	-3,000 Reduced 60.0%	2,000 $29,000
Q1 2019 Apr 15, 2019	SELL	$13.69 - $20.06 $982,942 - $1.44 Million	-71,800 Reduced 93.49%	5,000 $70,000
Q4 2018 Jan 22, 2019	SELL	$13.96 - $18.26 $3,280 - $4,291	-235 Reduced 0.31%	76,800 $1.34 Million
Q3 2018 Oct 15, 2018	SELL	$13.63 - $15.7 $11,244 - $12,952	-825 Reduced 1.06%	77,035 $1.17 Million
Q1 2018 Apr 25, 2018	BUY	$13.8 - $16.99 $414,000 - $509,699	30,000 Added 62.68%	77,860 $1.3 Million
Q4 2017 Feb 06, 2018	SELL	$11.73 - $14.75 $240,875 - $302,891	-20,535 Reduced 30.02%	47,860 $679,000
Q3 2017 Oct 11, 2017	BUY	$12.06 - $14.12 $824,843 - $965,737	68,395	68,395 $966,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Toth Financial Advisory Corp with notifications on news.